• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Device tax will “absolutely, directly, negatively influence job growth” | MassDevice.com On Call

Device tax will “absolutely, directly, negatively influence job growth” | MassDevice.com On Call

January 23, 2013 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — The 1st payments for the 2.3% medical device tax which took effect this year are due at the end of the month, and the burden of those new fees will "absolutely, directly, negatively influence job growth," BioMimetic Therapeutics founder Sam Lynch told reporters.

""The challenge of the tax is that it’s on revenue, not earnings, so for companies that might not be profitable already, it will hit harder," Lynch told the Nashville Biz Blog.

The tax took effect at the start of the year over the objections of the largest lobbying groups in the medtech industry, but the fight is not over.

North Star State legislator Sen. Al Franken conceded that repealing the tax will be more difficult now that it has taken effect, but he’s not giving up the fight.

"You’d be naive to say [implementation of the tax] doesn’t make it harder [to repeal]," Franken told the Star Tribune. "But I want to meet with folks from the industry here in the state and talk about different ways of … providing evidence that this [tax] might be counterproductive."

 Deadline passes for off-label marketing free speech rehearing
Federal regulators opt not to ask for a review of a U.S. Second Circuit Court of Appeals decision to protect a drug salesman’s off-label marketing as free speech.  
Read more

 Medical errors cost about $65M per year in liability payouts
Errors in the operating room occur about 80 times per week and cost about $1.3 billion in liability settlements over the course of 20 years, according to data collected from the National Practitioner Data Bank.  
Read more

 57k medical records exposed in children’s hospital theft
A laptop stolen from a pediatric physician’s care may have exposed 57,000 medical records containing names, dates of birth, medical histories and other information that doesn’t include social security numbers or credit card numbers.  
Read more

Filed Under: News Well Tagged With: BioMimetic Therapeutics Inc., On Call

More recent news

  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy